Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Vaccitech Plc ADR (VACC)

Vaccitech Plc ADR (VACC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise FinancialNewsMedia - Tue Sep 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

ONCY : 0.9478 (+2.99%)
BPTS : 8.22 (-15.28%)
VACC : 5.00 (+11.36%)
RNAZ : 4.97 (+9.23%)
ONC.TO : 1.42 (+2.16%)
BMY : 57.52 (+3.85%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONCY : 0.9478 (+2.99%)
BPTS : 8.22 (-15.28%)
VACC : 5.00 (+11.36%)
RNAZ : 4.97 (+9.23%)
ONC.TO : 1.42 (+2.16%)
BMY : 57.52 (+3.85%)
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment Business Wire - Wed Mar 29, 2023

Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s...

VACC : 5.00 (+11.36%)
Canadian CPI, U.S. Home Sales Featured Next Week Baystreet - Fri Mar 17, 2023

Monday U.S. Featured EarningsPDD Holdings Inc. (NASDAQ:PDD) (Q4) Reported EPS of $1.00, ...

VACC : 5.00 (+11.36%)
FL : 24.01 (-0.37%)
RETA : 172.36 (+0.02%)
AOT.TO : 0.0550 (unch)
CARE.TO : 5.14 (unch)
NKE : 40.75 (-0.37%)
ACN : 128.98 (+2.51%)
DCTH : 12.94 (+5.03%)
TME : 8.39 (+2.82%)
GIS : 36.01 (+1.72%)
PDD : 76.55 (+4.43%)
EXPR : 0.8300 (+18.57%)
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments Globe Newswire - Tue Aug 9, 2022

OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) today announced its financial results for the second quarter ended...

VACC : 5.00 (+11.36%)
Vaccitech to Present at the William Blair Biotech Focus Conference 2022 Globe Newswire - Thu Jul 7, 2022

OXFORD, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the...

VACC : 5.00 (+11.36%)

Barchart Exclusives

Nvidia and Broadcom Both Offer AI Exposure and Dividends. Barchart Data Helps Pick the Best Stock to Buy Now. Barchart - Fri Jun 26, 6:00PM CDT
Nvidia and Broadcom both offer AI exposure and dividends, but the better stock depends on what investors value most. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.